IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial
– ClinCloud has dosed its first patient in trial investigating the safety and efficacy of IGC-AD1 on agitation in Alzheimer’s Disease – POTOMAC, Md.–(BUSINESS WIRE)–#AD–IGC Pharma, Inc. (NYSE American: IGC)…
Details